About the event

Held over a weekend, the event is structured around a series of exhibitions, workshops, and panel discussions. The exhibitions showcase a curated selection of photographs that tell compelling stories from various corners of the globe, each image accompanied by detailed narratives that provide context and deeper insight into the historical significance of the scenes depicted. These photographs are drawn from the archives of renowned photographers, as well as emerging talents, ensuring a blend of both classical and contemporary perspectives.

Cliff Palace, Colorado
Ratios Reveal: Breaking Down Apimeds Pharmaceuticals US Inc (APUS)’s Financial Health – DwinneX

Ratios Reveal: Breaking Down Apimeds Pharmaceuticals US Inc (APUS)’s Financial Health

Nora Barnes

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

Apimeds Pharmaceuticals US Inc (AMEX: APUS) closed the day trading at $2.19 up 12.31% from the previous closing price of $1.95. In other words, the price has increased by $12.31 from its previous closing price. On the day, 0.12 million shares were traded. APUS stock price reached its highest trading level at $2.4 during the session, while it also had its lowest trading level at $1.97.

Ratios:

For a better understanding of APUS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.34 and its Current Ratio is at 8.34. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.00.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 13 ’25 when Kim Christopher bought 19,770 shares for $1.82 per share. The transaction valued at 35,981 led to the insider holds 19,770 shares of the business.

Kim Christopher bought 7,730 shares of APUS for $14,378 on May 14 ’25. The Chairman and CMO now owns 27,500 shares after completing the transaction at $1.86 per share. On May 12 ’25, another insider, Koo Jakap, who serves as the Director of the company, bought 28,500 shares for $1.99 each. As a result, the insider paid 56,715 and bolstered with 643,885 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APUS now has a Market Capitalization of 27541404 and an Enterprise Value of 21054886.

Stock Price History:

Over the past 52 weeks, APUS has reached a high of $4.03, while it has fallen to a 52-week low of $1.37. The 50-Day Moving Average of the stock is 1.75%, while the 200-Day Moving Average is calculated to be 12.59%.

Shares Statistics:

Over the past 3-months, APUS traded about 94.44K shares per day on average, while over the past 10 days, APUS traded about 125750 shares per day. A total of 12.58M shares are outstanding, with a floating share count of 3.09M. Insiders hold about 75.44% of the company’s shares, while institutions hold 3.18% stake in the company. Shares short for APUS as of 1763078400 were 20806 with a Short Ratio of 0.22, compared to 1760486400 on 41471.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.